Abstract
Epstein-Barr virus (EBV) replication contributes to multiple human diseases, including infectious mononucleosis, nasopharyngeal carcinoma, B cell lymphomas, and oral hairy leukoplakia. We performed systematic quantitative analyses of temporal changes in host and EBV proteins during lytic replication to gain insights into virus-host interactions, using conditional Burkitt lymphoma models of type I and II EBV infection. We quantified profiles of >8,000 cellular and 69 EBV proteins, including >500 plasma membrane proteins, providing temporal views of the lytic B cell proteome and EBV virome. Our approach revealed EBV-induced remodeling of cell cycle, innate and adaptive immune pathways, including upregulation of the complement cascade and proteasomal degradation of the B cell receptor complex, conserved between EBV types I and II. Cross-comparison with proteomic analyses of human cytomegalovirus infection and of a Kaposi-sarcoma-associated herpesvirus immunoevasin identified host factors targeted by multiple herpesviruses. Our results provide an important resource for studies of EBV replication.
Citations
Feb 2, 2018·Viruses·Makda GebreBenjamin E Gewurz
Mar 13, 2018·Nucleic Acids Research·Maja BencunHenri-Jacques Delecluse
Feb 16, 2018·Journal of Virology·Xiaohui MoQiliang Cai
Jun 5, 2018·PLoS Pathogens·Reza DjavadianEric Johannsen
Sep 25, 2018·PLoS Pathogens·Calum ForrestJianmin Zuo
Oct 26, 2018·Journal of Virology·Vladimir MajerciakZhi-Ming Zheng
Jan 8, 2019·PLoS Pathogens·Yan ChenRebecca L Skalsky
Jan 18, 2018·Molecular Neurodegeneration·Dong Kyu KimInhee Mook-Jung
Feb 1, 2019·Journal of Virology·Adityarup ChakravortyEric C Johannsen
May 28, 2019·Virologica Sinica·Meng MiaoXiaolu Zhao
Sep 4, 2019·Nature Reviews. Microbiology·Christian Münz
Nov 21, 2019·Proceedings of the National Academy of Sciences of the United States of America·Thejaswi NagarajuBill Sugden
Jan 17, 2020·Journal of Virology·Tiffany R FreySumita Bhaduri-McIntosh
Sep 14, 2019·PLoS Pathogens·Liang Wei WangBenjamin E Gewurz
Jun 11, 2020·Cancers·Diego GerminiYegor Vassetzky
Feb 6, 2020·PloS One·Ryan Douglas EstepScott W Wong
Jan 23, 2018·PLoS Pathogens·Dong-Wen LvRenfeng Li
May 5, 2018·Cancers·Marshall Williams, Maria Eugenia Ariza
Oct 23, 2019·Frontiers in Immunology·Korbinian BöslRichard K Kandasamy
Jun 18, 2020·Frontiers in Microbiology·Werner J D OuwendijkGeorges M G M Verjans
Apr 2, 2020·Seminars in Immunopathology·Alexander Buschle, Wolfgang Hammerschmidt
Nov 20, 2019·Virology·Kun ZhangRenfeng Li
Oct 8, 2020·Cell Reports·Timothy K SohColin M Crump
Oct 29, 2020·MBio·Yuchen ZhangBenjamin E Gewurz
Feb 18, 2021·PLoS Biology·Michiel van GentMichaela U Gack
May 3, 2019·Cell Reports·Edward J D GreenwoodPaul J Lehner
May 7, 2021·Journal of Virology·Melissa L WhyteAmy W Hudson
Jun 3, 2021·Viruses·Christian Münz
Jun 16, 2021·Annual Review of Virology·Alice Fletcher-Etherington, Michael P Weekes